Neuropsychological Evaluation of Psychiatric and Neurological Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00001192

Enrollment

4300

Registered

1999-11-04

Start date

1983-10-18

Completion date

2006-12-20

Last updated

2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder, Head Injury, Mood Disorder, Schizophrenia, Seizures

Keywords

Executive Functions, Language, Attention, Visual-Spatial Ability, Memory, Motor Behavior, Intelligence, Personality, Visual and Auditory Functioning, Hand and Eye Dominance, Normal Volunteer, Neuropsychiatric Disorders

Brief summary

This study will allow researchers to use various types of tests to evaluate cognitive and sensory functions. These tests, referred to as batteries will evaluate attention, executive functions, general intellectual functioning, language, memory, motor functions, orientation, personality, selected sensory and perceptual functions, vigilance (alertness), and visual-spatial functions. Children and adult patient will receive different test batteries. The goals of this research study are to; 1. Create descriptions based on the performance of each patient on the test batteries. Then use this information to relate patient behavior to their neurophysiological, neuroradiological, and biochemical descriptions. 2. Define subgroups of patients based on their neurobehavior in order to decrease the variability of psychiatric diagnoses, treatments, and prognoses.

Detailed description

Neuropsychological tests are used to provide an assessment of cognitive functions in patients with idiopathic generalized epileptic (IGE) disorders and their first-degree relatives. The battery comprises tests designed to tap attention, memory, selected sensory and perceptual functions, vigilance, and visual-spatial functions. Modified batteries have been developed for the assessment of children ages 5-8, and children ages 8-16. The data provided by these batteries are compared with genetic profiles of the same participants that have been ascertained from blood samples analyzed by colleagues at the Mount Sinai School of Medicine/Columbia University in New York City.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

No minimum to 95 Years

Healthy volunteers

Yes

Inclusion criteria

* INCLUSION CRITERIA: Patients. Normal volunteers.

Exclusion criteria

Subjects over 95 years of age. Subjects with a history of alcohol or drug abuse, psychopathology, or central nervous system pathology, other than that which defines group membership, may be excluded.

Countries

France, Russia, United States

Outcome results